BioCentury
ARTICLE | Company News

BioNTech gets rights to modified mRNA patents from Cellscript

October 20, 2017 6:09 PM UTC

In September, cancer immunotherapy company BioNTech AG (Mainz, Germany) said it received non-exclusive rights from Cellscript LLC (Madison, Wis.) to patents covering nucleoside-modified mRNA for use in all in vivo applications, including therapeutic and non-therapeutic applications in humans and animals. ...

BCIQ Company Profiles

BioNTech SE